期刊文献+

住院糖尿病患者中恶性肿瘤患病状况的调查 被引量:5

Study the prevalence of malignant tumor in hospitalized patients with diabetes
下载PDF
导出
摘要 目的:调查住院糖尿病患者恶性肿瘤的患病状况及其危险因素。方法回顾性分析南方医科大学附属南海医院4632例住院糖尿病患者的临床资料,统计出恶性肿瘤的患病及分布情况;分别按糖尿病病程及糖尿病血糖控制情况进行分层,对比分析其恶性肿瘤患病率的差异;对糖尿病患者恶性肿瘤患病的危险因素进行多因素分析。结果住院糖尿病患者,恶性肿瘤的检出率为7.82%,其中前3位为肠癌、肺癌、肝癌分别占20.71%、18.78%、15.19%;患病高峰年龄在50-70岁,占65.76%。血糖控制不达标患者恶性肿瘤患病率高(P <0.05),糖尿病病程10年以上者恶性肿瘤的患病率高(P <0.05)。多因素非条件 logistic 回归分析示年龄、性别、吸烟、糖尿病长病程、血糖控制不达标患者发生恶性肿瘤的 OR(95%CI)分别为1.854(1.343~3.922)、1.791(1.138~3.664)、1.989(1.232~3.823)、1.826(1.312~4.126)、1.925(1.435~4.306)。结论住院的糖尿病患者恶性肿瘤的患病率较高,高龄、男性、吸烟、糖尿病长病程及血糖控制不达标是糖尿病患者发生恶性肿瘤的危险因素。 Objective Explore the prevalence of malignant tumor and its related risk factors in hospitalized patients with diabetes.Methods A total of 4632 hospitalized patients with diabetes in Affiliated Nanhai Hospital of Southern Medical University were recruited from 2009 to 2012.The rate of diabetic patients with malignant tumor was calculated and the cancers distribution was analyzed.According to diabetic duration and the level of blood glucose control,the group was divided to compare the difference of the rate.The risk factors was confirmed by multifactor regression analy-sis.Results The detection rate of malignant tumor in hospitalized patients with diabetes was about 7.82%.The top three cancers were colorectal cancer(20.71%),lung cancer(18.78%)and liver cancer(15.19%).The top age of mor-bidity was 50~70 (65.76%).The diabetic duration and the level of blood glucose control could influence the detection rate.The OR(95%CI)of senility,male,smoking,long diabetes duration,substandard of blood glucose for development of malignant tumor were 1.854(1.343 ~ 3.922)、1.791 (1.138 ~ 3.664)、1.989 (1.232 ~ 3.823)、1.826 (1.312 ~4.126)、1.925(1.435~4.306).Conclusion The prevalence of malignant tumor is high and the elderly male,smoking, long diabetes duration,substandard of blood glucose are risk factors for development of malignant tumor in hospitalized patients with diabetes.
出处 《中国实验诊断学》 2014年第4期564-567,共4页 Chinese Journal of Laboratory Diagnosis
基金 佛山市医学科技攻关项目(2012ZD002)
关键词 糖尿病 恶性肿瘤 患病率 危险因素 Diabetes mellitus malignant tumor prevalence risk factors
  • 相关文献

参考文献12

  • 1Hemminki K, Li X, Sundquist J, et al. Risk of cancer following hospitalization for type 2 diabetes[J]. Oncologist, 2010,15 (6) : 548.
  • 2代敏,任建松,李霓,李倩,杨琳,陈玉恒.中国2008年肿瘤发病和死亡情况估计及预测[J].中华流行病学杂志,2012,33(1):57-61. 被引量:161
  • 3Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in ChinaJ]. N Engl J Med,2010,362(12) :1090.
  • 4Grote VA, Becket s, Kaaks R. Diabetes mellitus type 2 an inde- pendent risk factor for cancerJ]. Exp Clin Endocrinol Diabetes, 2010,118(1) :4.
  • 5Viagneri P,Frasca F,Sciacca L,et al. Diabetes and cancer [J]. En- docr Relat Cancer,2009,16(4): 1103.
  • 6张思维,雷正龙,李光琳,邹小农,赵平,陈万青.中国肿瘤登记地区2006年肿瘤发病和死亡资料分析[J].中国肿瘤,2010,19(6):356-365. 被引量:192
  • 7张园园,林健才,朱翠颜.2004至2010年中山大学附属江门医院住院2型糖尿病患者伴恶性肿瘤分布情况的回顾性调查[J].中华糖尿病杂志,2012,4(7):407-411. 被引量:9
  • 8Barone BB,Yeh Hc,Snyder CF,et al. Long term all-cause mortal- ity in cancer patients with pressxisting diabetes mellitus : asystem- atic review and recta-analysis[J]. JAMA,2008,300(23):2754.
  • 9Tran TT, Naigamwalla D, Oprescu AI, et al. Hyperinsulinemia, but not other factors associated with insulin resistance, acutely enhances colorectal epithelial proliferation in vivo[,J]. Endocrinol- ogy,2006,147(4) : 1830.
  • 10Chowdhury TA. Diabetes and cancer[,J]. QJM, 2010,103 (12) : 905.

二级参考文献26

  • 1张思维,雷正龙,李光琳,邹小农,陈万青,赵平.中国肿瘤登记地区2005年发病死亡资料分析[J].中国肿瘤,2009,18(12):973-979. 被引量:32
  • 2杨玲,李连弟,陈育德,Donald Maxwell Parkin.中国肺癌死亡趋势分析及发病、死亡的估计与预测[J].中国肺癌杂志,2005,8(4):274-278. 被引量:168
  • 3贺宇彤,侯浚,陈志峰,宋国慧,乔翠云,孟凡书,冀洪新,陈超.河北省磁县近三十年食管癌发病死亡趋势分析[J].中华流行病学杂志,2006,27(2):127-131. 被引量:40
  • 4杨玲,李连弟,陈育德,D.M.Parkin.中国乳腺癌发病死亡趋势的估计与预测[J].中华肿瘤杂志,2006,28(6):438-440. 被引量:278
  • 5陈竺.全国第三次死因回顾抽样调查报告.北京:中国协和医科大学出版社,2008.1417.
  • 6李连弟,陈育德.中国恶性肿瘤死亡调查研究(1990-1992).北京:人民卫生出版社,2008.
  • 7Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I : comparability, validity and timeliness [J]. Eur J Cancer, 2009, 45: 747-755.
  • 8Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents, Vol. IX. IARC scientific: publications No. 160[M], Lyon: IARC, 2007.
  • 9Parkin DM, Chen VM, Ferlay J, et al. Comparability and quality control in cancer registration. IARC technical report No.19[M]. Lyon: IARC, 1994.
  • 10Felay J, Bnrkhard C, Whelan S, et al. Check and conversion programs for cancerregistries. IARC Technical Report No. 42[M]. Lyon: IARC, 2005.

共引文献359

同被引文献36

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部